Hutch News

Hutch News

Stories tagged 'VIDD Research Interests'

Highlights of Fred Hutch science in 2018

A look back at notable advances in immunotherapy, precision screening and more

Dec. 18, 2018 | By Fred Hutch News Service staff

From basic biology to survivors’ pocketbooks, our researchers explore every angle of cancer. Here are just a few of the strides our teams made in 2018.

View story >


Exploring why people with HIV have a higher risk of lung cancer

120 volunteers to enroll in Seattle-area study of cancer-related gene mutations

Dec. 4, 2018 | By Sabin Russell / Fred Hutch News Service

Researchers Fred Hutch announced on Dec. 1 the start of a new study with a goal to understand why those who are HIV-positive are at higher risk of lung cancer.

View story >


'Cautiously optimistic' about HIV vaccines

A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey

Nov. 30, 2018 | By Sabin Russell / Fred Hutch News Service

In advance of World AIDS Day on Dec. 1, former Fred Hutch President and Director Dr. Larry Corey said he is "cautiously optimistic" about the current HIV vaccine trials. A renowned virologist, Corey has been a pioneer in HIV research since the beginning of the pandemic.

View story >


Persistent HIV infection works a lot like cancer, study shows

Ecology-inspired analysis suggests why reservoirs of HIV linger in treated patients

Nov. 19, 2018 | By Sabin Russell / Fred Hutch News Service

A study led by Drs. Joshua Schiffer and Daniel Reeves suggests that HIV persists in patients despite antiviral treatment through the natural duplication of blood cells that have HIV DNA embedded in their genes, and might be addressed by drugs that suppress such proliferation.

View story >


Study aims to cure blood cancers with transplants that could block HIV, too

10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene

Nov. 16, 2018 | By Sabin Russell / Fred Hutch News Service

Fred Hutch is about to lead a clinical trial offering cord blood transplants to blood cancer patients who also have HIV. The tranplants will carry a genetic trait that naturally confers resistance to HIV, so there is a possibility these transplants might also cure their HIV.

View story >


Fred Hutch deepens its focus on the microbiome

Microbiome Research Initiative hosts 2-day symposium

Sept. 20, 2018 | By Sabin Russell / Fred Hutch News Service

Fred Hutch hosted a two-day symposium on how the microbiome may interact with the immune system and play a role in the prevention or treatment of cancer.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.